Compare DHX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DHX | ACOG |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | Canada |
| Employees | N/A | 57 |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.7M | 110.4M |
| IPO Year | 2007 | N/A |
| Metric | DHX | ACOG |
|---|---|---|
| Price | $2.88 | $6.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.25 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 197.2K | 41.7K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $127,826,000.00 | N/A |
| Revenue This Year | N/A | $139.22 |
| Revenue Next Year | $3.52 | $134.48 |
| P/E Ratio | $70.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.44 | $4.50 |
| 52 Week High | $3.34 | $10.88 |
| Indicator | DHX | ACOG |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 50.63 |
| Support Level | $2.67 | $5.00 |
| Resistance Level | $3.01 | $6.59 |
| Average True Range (ATR) | 0.18 | 0.44 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 66.23 | 40.91 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.